Categories
BT Catalyst

Biotech Forum dates, topics set

Biotech Forum dates, topics set The 2005-06 season of Biotech Forums got under way in September with a program introducing five new biotechnology companies in the state. Dates and topics have been set for six more Forums running through next May at the Charles Hamner Conference Center of the North Carolina Biotechnology Center. The Forums, […]

Categories
BT Catalyst

Aurora closes on $85m fund

Aurora closes on $85m fund Aurora Funds Inc. of Durham has closed on a Fourth venture fund totaling $85 million that will Fuel the growth of entrepreneurial life-science and information-technology companies in the Southeast and Mid-Atlantic states. While the nation has seen a steady decline in both the size and number of venture funds, Aurora […]

Categories
BT Catalyst

Calendar

Calendar Jan. 13. Biotechnology Forum. Topic: IP Strategies for Emerging Biotechnology Companies. Time: 5:00 p.m. to 7:30 p.m. Place: North Carolina Biotechnology Center, Research Triangle Park. Cost: For discounts you are encouraged to register early at www.cednc.org. Feb. 19. The Laboratory Robotics Interest Group Technology Exhibition. Over 80 vendor booths and several robotics demonstrations. Time: […]

Categories
BT Catalyst

Mwg Biotech Opens High Point Facility

Mwg Biotech Opens High Point Facility MWG Biotech Inc., headquartered in Ebersberg, Germany, recently celebrated the grand opening of its Customer Biotechnology Center in High Point. The genomics company will use the new center as a demonstration site for automated biosystems, arrayers and scanners and customer scientific workshops. The facility will also include a technical […]

Categories
BT Catalyst

Xanthon Inc

http://www.looksmart.com/ http://www.findarticles.com/ FindArticles > BT Catalyst > July, 2001 > Article > Print friendly Xanthon Inc Xanthon Inc. of Research Triangle Park and the University of North Carolina at Chapel Hill (UNC) have been granted Australian patent 729118 for methods and an electrochemical apparatus for performing potenriometric analyses for the detection of specific binding between […]

Categories
BT Catalyst

Scynexis Raises $15m; Opens Near Rtp

Scynexis Raises $15m; Opens Near Rtp Scynexis Chemistry & Automation Inc. of Research Triangle Park officially opened for business recently after receiving $15 million in funding from a syndicate of venture capitalists and banks. Created by the spin-off of an Aventis CropScience research team, Scynexis will provide a comprehensive range of discovery chemistry services for […]

Categories
BT Catalyst

Synpac/Genzyme Deal Worth $19.5m

Synpac/Genzyme Deal Worth $19.5m Synpac (North Carolina) Inc. of Research Triangle Park and Genzyme General (Nasdaq: GENZ) of Cambridge, Mass., have formed an agreement in which Genzyme will obtain exclusive, worldwide rights to develop and commercialize Synpac’s [Pompase.sup.TM] enzyme replacement therapy for Pompe disease. Synpac will receive an initial payment of $19.5 million for the […]

Categories
BT Catalyst

Pilot Therapeutics Holdings Inc

Pilot Therapeutics Holdings Inc – News Briefs * Pilot Therapeutics Holdings Inc. (OTC Bulletin Board: PLTT.OB) of Winston-Salem has completed a pediatric trial for Airosin[TM], its lead over-the-counter medical food product for pediatric and adult asthma. The oral, once-a-day product was shown to inhibit the production of leukotrienes, which contribute to the severity of asthma […]

Categories
BT Catalyst

North Carolina Biotechnology Center grants $525,000 in awards

North Carolina Biotechnology Center grants $525,000 in awards Four small biotechnology companies have received loans totaling $525,000 from the North Carolina Biotechnology Center to advance their research on gene delivery and potential treatments for asthma, diabetes and HIV. Oriel Therapeutics Inc. and Tranzyme Inc., both based in Research Triangle Park, and Ribonomics Inc. of Durham […]

Categories
BT Catalyst

Paradigm Genetics Inc

Paradigm Genetics Inc Michael Liebman, Ph.D., has been appointed to the scientific advisory board of Paradigm Genetics Inc. (Nasdaq: PDGM) of Research Triangle Park. Liebman is the director of biomedical informatics at the Abramson Family Cancer Research Institute at the University of Pennsylvania School of Medicine in Philadelphia. Also, Brian R. Bullard has been named […]